Market Research Logo

Asia Pacific Companion Diagnostics Market Forecast 2018-2026

Asia Pacific Companion Diagnostics Market Forecast 2018-2026
KEY FINDINGS

The Asia-Pacific companion diagnostics market is predicted to show the highest CAGR of 18.79% over the forecast period of 2018-2026. China, India and Japan are the major contributors to this market.

MARKET INSIGHTS

Growing pharmaceutical sector, research and development in genomics and increased research spending are driving growth in the Asia-Pacific companion diagnostics market. In the year 2017, China contributed the highest revenue share to this region. In 2015, the Chinese Academy of Sciences issued invitations to apply for funding for projects under the China Precision Medicine Initiatives (PMI). Such initiatives are highly beneficial for market growth. However, issues related to intellectual property rights are major threats to this market.

COMPETITIVE INSIGHTS

Companies like Abbott Laboratories, Arup Laboratories, Qiagen N.V, Almac Group, Ge Healthcare, Sysmex Corporation, Thermo Fisher Scientific Inc, Danaher Corporation, Illumina Inc, Roche Diagnostics (A Hoffmann-La Roche Ag Divison), Genomic Health and Biocartis are catering to this market.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Oncology Market To Hold The Largest Market Share In Terms Of Indicator
3.2.2. Assay Kits And Reagents Are Significantly Used In Terms Of Product And Service
3.2.3. Increasing Cancer Incidence In Asia Pacific
3.2.4. Next Generation Sequencing Is Growing Significantly
4. Market Determinants
4.1. Market Drivers
4.1.1. Rising Demand For Targeted Therapy
4.1.2. Increasing Prevalence Of Cancer
4.1.3. Swelling Strategic Initiatives For Companion Diagnostics Test Development
4.2. Market Restraints
4.2.1. Issues Related To Intellectual Property Rights
4.3. Market Opportunity
4.3.1. Focused On Implementing Companion Diagnostics Due To Rising New Indication Areas
4.3.2. Growing Demand For Next-generation Sequencing
4.3.3. Escalating Number Of Clinical Trials In Companion Diagnostics
4.4. Market Challenges
4.4.1. Prolonged Development Time Of Companion Diagnostics
4.4.2. Lengthy Approval Process
5. Market Segmentation
5.1. Market By Products And Services 2018-2026
5.1.1. Assay Kits And Reagents
5.1.2. Software And Service
5.2. Market By Indication 2018-2026
5.2.1. Oncology
5.2.2. Neurology
5.2.3. Infectious Diseases
5.2.4. Other Indications
5.3. Market By End User 2018-2026
5.3.1. Pharmaceutical And Biopharmaceutical Companies
5.3.2. Reference Laboratories
5.3.3. Other End Users
5.4. Market By Technology 2018-2026
5.4.1. In Situ Hybridization
5.4.2. Polymerase Chain Reaction
5.4.3. Immunohistochemistry
5.4.4. Next Generation Sequencing
5.4.5. Other Technologies
6. Key Analytics
6.1. Porter’s 5 Force Analysis
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Etymology Of Companion Diagnostics
6.3. Supply Chain Analysis
6.4. Key Buying Criteria
6.5. Regulatory Framework
6.6. Estimation Analysis
7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. India
7.1.3. Japan
7.1.4. Australia
7.1.5. South Korea
7.1.6. Rest Of Asia Pacific
8. Company Profiles
8.1. Competitive Landscape
8.2. Abbott Laboratories.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Almac Group
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Arup Laboratories
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.5. Biocartis
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Biomerieux S.A
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.7. Danaher Corporation
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Ge Healthcare
8.8.1. Company Overview
8.8.2. Products Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Genomic Health
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Illumina, Inc.
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Myriad Genetics, Inc.
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Qiagen N.V.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Roche Diagnostics (A Hoffmann-la Roche Ag Divison)
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Sysmex Corporation
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Thermo Fisher Scientific, Inc.
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives
Table List
Table 1 Asia Pacific Companion Diagnostics Market 2018-2026 ($ Million)
Table 2 Asia Pacific Companion Diagnostics Market By Product And Service 2018-2026 ($ Million)
Table 3 Asia Pacific Companion Diagnostics Market In Assay Kits And Reagents 2018-2026 ($ Million)
Table 4 Asia Pacific Companion Diagnostics Market In Software And Service 2018-2026 ($ Million)
Table 5 Asia Pacific Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 6 Asia Pacific Companion Diagnostics Market In Oncology 2018-2026 ($ Million)
Table 7 Asia Pacific Companion Diagnostics Market In Neurology 2018-2026 ($ Million)
Table 8 Asia Pacific Companion Diagnostics Market In Infectious Diseases 2018-2026 ($ Million)
Table 9 Asia Pacific Companion Diagnostics Market In Other Indications 2018-2026 ($ Million)
Table 10 Asia Pacific Companion Diagnostics Market By End User 2018-2026 ($ Million)
Table 11 Asia Pacific Companion Diagnostics Market In Pharmaceutical And Biopharmaceutical Companies 2018-2026 ($ Million)
Table 12 Asia Pacific Companion Diagnostics Market In Reference Laboratories 2018-2026 ($ Million)
Table 13 Asia Pacific Companion Diagnostics Market In Other End Users 2018-2026 ($ Million)
Table 14 Asia Pacific Companion Diagnostics Market By Technology 2018-2026 ($ Million)
Table 15 Asia Pacific Companion Diagnostics Market In In Situ Hybridization 2018-2026 ($ Million)
Table 16 Asia Pacific Companion Diagnostics Market In Polymerase Chain Reaction 2018-2026 ($ Million)
Table 17 Asia Pacific Companion Diagnostics Market In Immunohistochemistry 2018-2026 ($ Million)
Table 18 Asia Pacific Companion Diagnostics Market In Next Generation Sequencing 2018-2026 ($ Million)
Table 19 Asia Pacific Companion Diagnostics Market In Other Technologies 2018-2026 ($ Million)
Table 20 Asia Pacific Companion Diagnostics Market By Countries 2018-2026 ($ Million)
Table 21 China Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 22 India Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 23 Japan Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Table 24 Australia Companion Diagnostics Market By Indication 2018-2026 ($ Million)
Figures List
Figure 1 Asia Pacific Companion Diagnostics Market 2018-2026 ($ Million)
Figure 2 Growing Number Of People With Cancer Worldwide
Figure 3 Supply Chain Analysis Of Companion Diagnostics Industry
Figure 4 Key Buying Criteria
Figure 5 Newly Registered Clinical Trial Study 2016-2018
Figure 6 China Companion Diagnostics Market 2018-2026 ($ Million)
Figure 7 India Companion Diagnostics Market 2018-2026 ($ Million)
Figure 8 Japan Companion Diagnostics Market 2018-2026 ($ Million)
Figure 9 Australia Companion Diagnostics Market 2018-2026 ($ Million)
Figure 10 South Korea Companion Diagnostics Market 2018-2026 ($ Million)
Figure 11 Rest Of Asia Pacific Companion Diagnostics Market 2018-2026 ($ Million)
Figure 12 Company Market Share Of Asia Pacific Companion Diagnostics Market 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report